end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccretionExpense,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapitalCommonStock,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,Assets,AssetsCurrent,AvailableForSaleSecuritiesDebtSecuritiesCurrent,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,ClassOfWarrantOrRightOutstanding,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ComprehensiveIncomeNetOfTax,DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction,DeferredOfferingCosts,DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage,DepositsAssetsNoncurrent,DepreciationDepletionAndAmortization,EarningsPerShareBasicAndDiluted,EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset,EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet,EmployeeRelatedLiabilitiesCurrent,EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions,FairValueAssetsLevel1ToLevel2TransfersAmount,FairValueAssetsLevel2ToLevel1TransfersAmount,FairValueLiabilitiesLevel1ToLevel2TransfersAmount,FairValueLiabilitiesLevel2ToLevel1TransfersAmount,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3,FinanceLeaseInterestExpense,FinanceLeaseLiability,FinanceLeaseLiabilityPaymentsDue,FinanceLeaseLiabilityPaymentsDueNextTwelveMonths,FinanceLeaseLiabilityPaymentsDueYearFour,FinanceLeaseLiabilityPaymentsDueYearThree,FinanceLeaseLiabilityPaymentsDueYearTwo,FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear,FinanceLeaseLiabilityUndiscountedExcessAmount,FinanceLeasePrincipalPayments,GainLossOnSaleOfPropertyPlantEquipment,GainsLossesOnExtinguishmentOfDebt,GeneralAndAdministrativeExpense,ImpairmentOfInvestments,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInDepositOtherAssets,IncreaseDecreaseInOtherOperatingLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,InterestExpenseRelatedParty,InvestmentIncomeNet,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,LettersOfCreditOutstandingAmount,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebtNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAvailableToCommonStockholdersBasic,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OtherAssetsCurrent,OtherComprehensiveIncomeLossNetOfTax,OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherSundryLiabilitiesCurrent,PaymentsToAcquireInProcessResearchAndDevelopment,PaymentsToAcquirePropertyPlantAndEquipment,PaymentsToAcquireShortTermInvestments,PrepaidExpenseCurrent,ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,ResearchAndDevelopmentInProcess,RetainedEarningsAccumulatedDeficit,SaleLeasebackTransactionNetBookValue,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1,StockholdersEquity,StockholdersEquityNoteStockSplitConversionRatio1,StockIssued1,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,TemporaryEquityDividendsAdjustment,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AmortizationOfDebtDiscountPremium,CashCashEquivalentsAndShortTermInvestments,DeferredFederalIncomeTaxExpenseBenefit,DeferredIncomeTaxExpenseBenefit,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsGross,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther,DeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,FinanceLeaseLiabilityCurrent,FinanceLeaseLiabilityNoncurrent,FinanceLeaseLiabilityPaymentsDueYearFive,IncreaseDecreaseInEmployeeRelatedLiabilities,IncreaseDecreaseInOtherCurrentAssets,IncreaseDecreaseInPrepaidExpense,LongTermDebt,MarketableSecuritiesCurrent,NumberOfOperatingSegments,OtherAssetsNoncurrent,PaymentsOfFinancingCosts,PreferredStockDividendRatePercentage,ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments,ProceedsFromSaleOfPropertyPlantAndEquipment,ProceedsFromSaleOfShortTermInvestments,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,StockIssuedDuringPeriodSharesStockOptionsExercised,StockIssuedDuringPeriodValueEmployeeStockPurchasePlan,UnrecognizedTaxBenefits,ValuationAllowanceDeferredTaxAssetChangeInAmount
2020-12-31,2021-03-30,10-K,"Sensei Biotherapeutics, Inc.",SNSE,CIK0001829802,USD,3882000.0,1578000.0,595000.0,,55969000.0,1492000.0,1492000.0,21428000.0,20076000.0,,204000.0,16596000.0,16596000.0,16345000.0,7.62,57212.0,0.0001,250000000.0,1875422.0,1875422.0,,-20204000.0,,2105000.0,,86000.0,209000.0,-12.53,0.0,995000.0,916000.0,5900000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,,,,,,,,,41000.0,,45000.0,7528000.0,,,335000.0,,249000.0,,1689000.0,645000.0,,,,,,,,,,5535000.0,21428000.0,4830000.0,567000.0,35453000.0,-1403000.0,-17705000.0,-20100000.0,-20204000.0,19451000.0,-19451000.0,1439000.0,,,,948000.0,52000.0,32000.0,197000.0,1206000.0,,1375000.0,,-20100000.0,1861000.0,1266000.0,,738000.0,-112412000.0,,1492000.0,,1.0,0.9,0.007,0.001,,,13322.0,1899507.0,10284000.0,1947123.0,5.7,,,,119.38,2.02,,1100000.0,-56443000.0,,18050000.0,541000.0,47545000.0,,15000.0,104000.0,1612140.0,,,-2097000.0,-2527000.0,-430000.0,24755000.0,1364000.0,22271000.0,706000.0,414000.0,24755000.0,0.21,-0.126,-0.012,-0.002,-0.087,0.036,32000.0,86000.0,,-271000.0,-361000.0,1124000.0,567000.0,,,86000.0,2105000.0,,,,,100000.0,3.09,1.23,16666.0,,,2527000.0
2021-03-31,2021-05-13,10-Q,"Sensei Biotherapeutics, Inc.",SNSE,CIK0001829802,USD,2002000.0,,693000.0,,291633000.0,1349000.0,1349000.0,174476000.0,172785000.0,,15000.0,169418000.0,169418000.0,152822000.0,,,0.0001,1230000000.0,30588495.0,30588495.0,3000.0,,534000.0,,1.0,36000.0,98000.0,-0.42,,,440000.0,21400000.0,,,,,,,,,3000.0,111000.0,127000.0,41000.0,,14000.0,41000.0,31000.0,16000.0,10000.0,,,4604000.0,,0.0,-1880000.0,-50000.0,-423000.0,1992000.0,3000.0,0.0,,6387000.0,1192000.0,657000.0,1259000.0,1223000.0,1201000.0,796000.0,515000.0,3224000.0,174476000.0,2475000.0,567000.0,164076000.0,-487000.0,-10767000.0,-7972000.0,-7972000.0,7969000.0,-7969000.0,234000.0,60000.0,,,473000.0,182000.0,33000.0,,487000.0,,3307000.0,,-7972000.0,2348000.0,1655000.0,3365000.0,,-120384000.0,,1349000.0,,0.9804,0.915,0.01,0.005,446771.0,15.7,43749.0,1253825.0,23557000.0,3157199.0,10.6,18461000.0,2710428.0,9.76,6.0,18.06,5096000.0,1100000.0,171252000.0,,,,95828000.0,138489000.0,1000.0,,18904853.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-08-11,10-Q,"Sensei Biotherapeutics, Inc.",SNSE,CIK0001829802,USD,2828000.0,,744000.0,-101000.0,293378000.0,1745000.0,1745000.0,167724000.0,165613000.0,146899000.0,,15599000.0,15599000.0,,,,0.0001,1230000000.0,30588495.0,30588495.0,3000.0,-9872000.0,,,,,122000.0,-0.32,,,1095000.0,21000000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,,,,,,,-28000.0,,3886000.0,,0.0,,,,,147000.0,0.0,188000.0,8670000.0,1584000.0,1414000.0,1688000.0,1640000.0,1605000.0,680000.0,678000.0,4599000.0,167724000.0,3923000.0,567000.0,,,,-9771000.0,-9771000.0,9784000.0,-9784000.0,272000.0,472000.0,-101000.0,-101000.0,1095000.0,109000.0,,,,,2643000.0,,,2855000.0,2111000.0,,,-130155000.0,,,,,,,,607865.0,12.66,,,13648000.0,3214117.0,11.02,9158000.0,2606252.0,10.64,,,4490000.0,,163125000.0,,,,,,,,30588495.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"Sensei Biotherapeutics, Inc.",SNSE,CIK0001829802,USD,3614000.0,,879000.0,-69000.0,295114000.0,1736000.0,1736000.0,161249000.0,158162000.0,147129000.0,,9533000.0,9533000.0,,,,0.0001,1230000000.0,30588495.0,30588495.0,3000.0,-9653000.0,,,,27000.0,136000.0,-0.32,,,1615000.0,19700000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,898000.0,950000.0,239000.0,139000.0,239000.0,239000.0,94000.0,52000.0,,,567000.0,3873000.0,,0.0,,,,,214000.0,0.0,278000.0,8385000.0,1585000.0,1415000.0,1688000.0,1641000.0,1606000.0,391000.0,678000.0,6041000.0,161249000.0,5264000.0,,,,,-9685000.0,-9685000.0,10316000.0,-10316000.0,414000.0,301000.0,32000.0,32000.0,1650000.0,777000.0,35000.0,,,,1199000.0,,,3939000.0,3060000.0,,,-139840000.0,,,,,,,,793677.0,10.66,,,14804000.0,3264200.0,11.04,8494000.0,2470523.0,11.16,,,6310000.0,,155208000.0,,,,,,,,30588495.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-15,10-K,"Sensei Biotherapeutics, Inc.",SNSE,CIK0001829802,USD,2456000.0,,1189000.0,-333000.0,296049000.0,5657000.0,5657000.0,153225000.0,148542000.0,,,7159000.0,7159000.0,-9437000.0,,,0.0001,250000000.0,30609029.0,30609029.0,3000.0,-37127000.0,,,1.0,,685000.0,-1.33,,,1753000.0,16000000.0,,,0.0,0.0,0.0,0.0,0.0,0.0,57000.0,2354000.0,2647000.0,699000.0,553000.0,674000.0,674000.0,,293000.0,255000.0,-9000.0,567000.0,15820000.0,0.0,,-1426000.0,,205000.0,,670000.0,0.0,800000.0,7993000.0,1585000.0,1413000.0,1689000.0,1641000.0,1606000.0,,,6712000.0,153225000.0,4889000.0,,163940000.0,-143118000.0,-30259000.0,-36794000.0,-36794000.0,37482000.0,-37482000.0,1488000.0,374000.0,-333000.0,-333000.0,,149000.0,,,2026000.0,183669000.0,547000.0,,-36794000.0,5833000.0,4644000.0,,,-149206000.0,293000.0,5657000.0,,0.98,0.89,0.014,0.004,872570.0,9.82,652984.0,1741159.0,6403000.0,3026464.0,10.84,3051000.0,2153894.0,11.25,9.18,15.93,3352000.0,2800000.0,146513000.0,,,,95828000.0,138489000.0,28000.0,,27710686.0,,147600000.0,-6598000.0,-8303000.0,-1705000.0,33151000.0,1364000.0,27107000.0,1103000.0,408000.0,33151000.0,0.21,-0.226,-0.002,-0.008,,0.046,680000.0,1674000.0,47000.0,837000.0,327000.0,-828000.0,,140462000.0,1.0,39000.0,,0.08,31000000.0,318000.0,11259000.0,100000.0,12.12,1.23,8834.0,80000.0,0.0,8303000.0
